Artykuły w czasopismach na temat „Eotaxin”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Eotaxin”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Varlamov, E. E., T. V. Vinogradova, A. A. Chuslyaeva, T. S. Okuneva i A. N. Pampura. "BIOMARKERS ALLERGIC INFLAMATION AND SEVERITY OF ATOPIC DERMATITIS AT CHILDREN". Russian Journal of Allergy 9, nr 5 (15.12.2012): 31–35. http://dx.doi.org/10.36691/rja694.
Pełny tekst źródłaBadewa, A. P., C. E. Hudson i A. S. Heiman. "Regulatory Effects of Eotaxin, Eotaxin-2, and Eotaxin-3 on Eosinophil Degranulation and Superoxide Anion Generation1". Experimental Biology and Medicine 227, nr 8 (wrzesień 2002): 645–51. http://dx.doi.org/10.1177/153537020222700814.
Pełny tekst źródłaHaley, Kathleen J., Mary E. Sunday, Yolanda Porrata, Colleen Kelley, Anne Twomey, Aliakbar Shahsafaei, Benjamin Galper, Larry A. Sonna i Craig M. Lilly. "Ontogeny of the eotaxins in human lung". American Journal of Physiology-Lung Cellular and Molecular Physiology 294, nr 2 (luty 2008): L214—L224. http://dx.doi.org/10.1152/ajplung.00086.2007.
Pełny tekst źródłaVarlamov, E. E., O. G. Elisyutina, T. V. Vinogradova, E. S. Fedenko i A. N. Pampura. "AGE-RELATED PATHOGENTIC SPECIFICITY OF CYTOKINE PROFILE IN ATOPIC DERMATITIS PATIENTS". Russian Journal of Allergy 13, nr 4-5 (15.12.2016): 37–42. http://dx.doi.org/10.36691/rja358.
Pełny tekst źródłaDiny, Nicola, Xuezhou Hou, Jobert G. Barin, Monica V. Talor, Noel R. Rose i Daniela Cihakova. "The eotaxin-CCR3 pathway is required for eosinophil trafficking to the heart in eosinophilic myocarditis". Journal of Immunology 196, nr 1_Supplement (1.05.2016): 117.10. http://dx.doi.org/10.4049/jimmunol.196.supp.117.10.
Pełny tekst źródłaRothenberg, Marc E. "Eotaxin". American Journal of Respiratory Cell and Molecular Biology 21, nr 3 (wrzesień 1999): 291–95. http://dx.doi.org/10.1165/ajrcmb.21.3.f160.
Pełny tekst źródłaJo, Jung Hyun, Yong-Tae Kim, Ho Soon Choi, Ho Gak Kim, Hong Sik Lee, Young Woo Choi, Dong Uk Kim i in. "KG 4/2015: A randomized, controlled, multicenter, open-label phase III clinical trial of GV1001 with gemcitabine/capecitabine in previous untreated, eotaxin-high patients with advanced pancreatic ductal adenocarcinoma." Journal of Clinical Oncology 39, nr 15_suppl (20.05.2021): 4020. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.4020.
Pełny tekst źródłaBeal, Dominic R., David M. Stepien, Sudha Natarajan, Jiyoun Kim i Daniel G. Remick. "Reduction of eotaxin production and eosinophil recruitment by pulmonary autologous macrophage transfer in a cockroach allergen-induced asthma model". American Journal of Physiology-Lung Cellular and Molecular Physiology 305, nr 11 (1.12.2013): L866—L877. http://dx.doi.org/10.1152/ajplung.00120.2013.
Pełny tekst źródłaForssmann, Ulf, Mariagrazia Uguccioni, Pius Loetscher, Clemens A. Dahinden, Hanno Langen, Marcus Thelen i Marco Baggiolini. "Eotaxin-2, a Novel CC Chemokine that Is Selective for the Chemokine Receptor CCR3, and Acts Like Eotaxin on Human Eosinophil and Basophil Leukocytes". Journal of Experimental Medicine 185, nr 12 (16.06.1997): 2171–76. http://dx.doi.org/10.1084/jem.185.12.2171.
Pełny tekst źródłaStruyf, Sofie, Paul Proost, Dominique Schols, Erik De Clercq, Ghislain Opdenakker, Jean-Pierre Lenaerts, Michel Detheux i in. "CD26/Dipeptidyl-Peptidase IV Down-Regulates the Eosinophil Chemotactic Potency, But Not the Anti-HIV Activity of Human Eotaxin by Affecting Its Interaction with CC Chemokine Receptor 3". Journal of Immunology 162, nr 8 (15.04.1999): 4903–9. http://dx.doi.org/10.4049/jimmunol.162.8.4903.
Pełny tekst źródłaKomiya, A., H. Nagase, H. Yamada, T. Sekiya, M. Yamaguchi, Y. Sano, N. Hanai i in. "Concerted expression of eotaxin-1, eotaxin-2, and eotaxin-3 in human bronchial epithelial cells". Journal of Allergy and Clinical Immunology 111, nr 2 (luty 2003): S150. http://dx.doi.org/10.1016/s0091-6749(03)80481-5.
Pełny tekst źródłaKomiya, Akiko, Hiroyuki Nagase, Hirokazu Yamada, Takashi Sekiya, Masao Yamaguchi, Yasuyuki Sano, Nobuo Hanai i in. "Concerted expression of eotaxin-1, eotaxin-2, and eotaxin-3 in human bronchial epithelial cells". Cellular Immunology 225, nr 2 (październik 2003): 91–100. http://dx.doi.org/10.1016/j.cellimm.2003.10.001.
Pełny tekst źródłaRuth, Jeffrey H., Nicholas W. Lukacs, Kelly S. Warmington, Tim J. Polak, Marie Burdick, Steven L. Kunkel, Robert M. Strieter i Stephen W. Chensue. "Expression and Participation of Eotaxin During Mycobacterial (Type 1) and Schistosomal (Type 2) Antigen-Elicited Granuloma Formation". Journal of Immunology 161, nr 8 (15.10.1998): 4276–82. http://dx.doi.org/10.4049/jimmunol.161.8.4276.
Pełny tekst źródłaKhoury, Tawfik, Dory Rotnemer-Golinkin, Lidya Zolotarev i Yaron Ilan. "Orally administered anti-eotaxin-1 monoclonal antibody is biologically active in the gut and alleviates immune-mediated hepatitis: A novel anti-inflammatory personalized therapeutic approach". International Journal of Immunopathology and Pharmacology 35 (styczeń 2021): 205873842110212. http://dx.doi.org/10.1177/20587384211021215.
Pełny tekst źródłaTenscher, K., B. Metzner, E. Schopf, J. Norgauer i W. Czech. "Recombinant human eotaxin induces oxygen radical production, Ca(2+)- mobilization, actin reorganization, and CD11b upregulation in human eosinophils via a pertussis toxin-sensitive heterotrimeric guanine nucleotide-binding protein". Blood 88, nr 8 (15.10.1996): 3195–99. http://dx.doi.org/10.1182/blood.v88.8.3195.bloodjournal8883195.
Pełny tekst źródłaDas, A. M., R. J. Flower i M. Perretti. "Eotaxin-induced eosinophil migration in the peritoneal cavity of ovalbumin-sensitized mice: mechanism of action." Journal of Immunology 159, nr 3 (1.08.1997): 1466–73. http://dx.doi.org/10.4049/jimmunol.159.3.1466.
Pełny tekst źródłaMarleau, S., D. A. Griffiths-Johnson, P. D. Collins, Y. S. Bakhle, T. J. Williams i P. J. Jose. "Human RANTES acts as a receptor antagonist for guinea pig eotaxin in vitro and in vivo." Journal of Immunology 157, nr 9 (1.11.1996): 4141–46. http://dx.doi.org/10.4049/jimmunol.157.9.4141.
Pełny tekst źródłaOlze, H., U. Förster, T. Zuberbier, L. Morawietz i E. O. Luger. "Eotaxin-, Eotaxin-2-, Eotaxin-3- und RANTES-Proteinsynthese bei Polyposis nasi Korrelation zu Eosinophilie und Ätiologie". Allergologie 29, nr 03 (1.03.2006): 77–85. http://dx.doi.org/10.5414/alp29077.
Pełny tekst źródłaLuz, Ricardo Alves, Pedro Xavier-Elsas, Bianca de Luca, Daniela Masid-de-Brito, Priscila Soares Cauduro, Luiz Carlos Gondar Arcanjo, Ana Carolina Cordeiro Faria dos Santos, Ivi Cristina Maria de Oliveira i Maria Ignez Capella Gaspar-Elsas. "5-Lipoxygenase-Dependent Recruitment of Neutrophils and Macrophages by Eotaxin-Stimulated Murine Eosinophils". Mediators of Inflammation 2014 (2014): 1–13. http://dx.doi.org/10.1155/2014/102160.
Pełny tekst źródłaOgilvie, Patricia, Giuseppe Bardi, Ian Clark-Lewis, Marco Baggiolini i Mariagrazia Uguccioni. "Eotaxin is a natural antagonist for CCR2 and an agonist for CCR5". Blood 97, nr 7 (1.04.2001): 1920–24. http://dx.doi.org/10.1182/blood.v97.7.1920.
Pełny tekst źródłaYing, Sun, Douglas S. Robinson, Qiu Meng, Luis T. Barata, Alan R. McEuen, Mark G. Buckley, Andrew F. Walls, Philip W. Askenase i A. Barry Kay. "C-C Chemokines in Allergen-Induced Late-Phase Cutaneous Responses in Atopic Subjects: Association of Eotaxin with Early 6-Hour Eosinophils, and of Eotaxin-2 and Monocyte Chemoattractant Protein-4 with the Later 24-Hour Tissue Eosinophilia, and Relationship to Basophils and Other C-C Chemokines (Monocyte Chemoattractant Protein-3 and RANTES)". Journal of Immunology 163, nr 7 (1.10.1999): 3976–84. http://dx.doi.org/10.4049/jimmunol.163.7.3976.
Pełny tekst źródłaOgilvie, Patricia, Samantha Paoletti, Ian Clark-Lewis i Mariagrazia Uguccioni. "Eotaxin-3 is a natural antagonist for CCR2 and exerts a repulsive effect on human monocytes". Blood 102, nr 3 (1.08.2003): 789–94. http://dx.doi.org/10.1182/blood-2002-09-2773.
Pełny tekst źródłaIshii, Yukio, Manabu Shirato, Akihiro Nomura, Tohru Sakamoto, Yoshiyuki Uchida, Morio Ohtsuka, Masaru Sagai i Shizuo Hasegawa. "Cloning of rat eotaxin: ozone inhalation increases mRNA and protein expression in lungs of Brown Norway rats". American Journal of Physiology-Lung Cellular and Molecular Physiology 274, nr 1 (1.01.1998): L171—L176. http://dx.doi.org/10.1152/ajplung.1998.274.1.l171.
Pełny tekst źródłaKoç, Ümit, Erdinç Çetinkaya, Erdal B. Bostanci, Ahu S. Kemık, Mesut Tez, İsmail Gömceli i Musa Akoğlu. "Diagnostic Significance of Serum Eotaxin-1 Level in Gastric Cancer Patients". Disease Markers 35 (2013): 363–67. http://dx.doi.org/10.1155/2013/274515.
Pełny tekst źródłaFranz-Bacon, Karin, Daniel J. Dairaghi, Stefen A. Boehme, Susan K. Sullivan, Thomas J. Schall, Paul J. Conlon, Naomi Taylor i Kevin B. Bacon. "Human Thymocytes Express CCR-3 and Are Activated by Eotaxin". Blood 93, nr 10 (15.05.1999): 3233–40. http://dx.doi.org/10.1182/blood.v93.10.3233.410k33_3233_3240.
Pełny tekst źródłaRothenberg, M. E., A. D. Luster, C. M. Lilly, J. M. Drazen i P. Leder. "Constitutive and allergen-induced expression of eotaxin mRNA in the guinea pig lung." Journal of Experimental Medicine 181, nr 3 (1.03.1995): 1211–16. http://dx.doi.org/10.1084/jem.181.3.1211.
Pełny tekst źródłaYang, Yi, James Loy, Rolf-Peter Ryseck, Daniel Carrasco i Rodrigo Bravo. "Antigen-Induced Eosinophilic Lung Inflammation Develops in Mice Deficient in Chemokine Eotaxin". Blood 92, nr 10 (15.11.1998): 3912–23. http://dx.doi.org/10.1182/blood.v92.10.3912.422k23_3912_3923.
Pełny tekst źródłaRothenberg, Marc E., James A. MacLean, Eric Pearlman, Andrew D. Luster i Philip Leder. "Targeted Disruption of the Chemokine Eotaxin Partially Reduces Antigen-induced Tissue Eosinophilia". Journal of Experimental Medicine 185, nr 4 (17.02.1997): 785–90. http://dx.doi.org/10.1084/jem.185.4.785.
Pełny tekst źródłaVasudevan, Abu R., Huaizhu Wu, Antonios M. Xydakis, Peter H. Jones, E. O’Brian Smith, John F. Sweeney, David B. Corry i Christie M. Ballantyne. "Eotaxin and Obesity". Journal of Clinical Endocrinology & Metabolism 91, nr 1 (styczeń 2006): 256–61. http://dx.doi.org/10.1210/jc.2005-1280.
Pełny tekst źródłaPease, J. "Eotaxin and asthma". Current Opinion in Pharmacology 1, nr 3 (1.06.2001): 248–53. http://dx.doi.org/10.1016/s1471-4892(01)00044-3.
Pełny tekst źródłaDevouassoux, Gilles, Dean D. Metcalfe i Calman Prussin. "Eotaxin Potentiates Antigen-Dependent Basophil IL-4 Production". Journal of Immunology 163, nr 5 (1.09.1999): 2877–82. http://dx.doi.org/10.4049/jimmunol.163.5.2877.
Pełny tekst źródłaMatsukura, Satoshi, Cristiana Stellato, James R. Plitt, Carol Bickel, Katsushi Miura, Steve N. Georas, Vincenzo Casolaro i Robert P. Schleimer. "Activation of Eotaxin Gene Transcription by NF-κB and STAT6 in Human Airway Epithelial Cells". Journal of Immunology 163, nr 12 (15.12.1999): 6876–83. http://dx.doi.org/10.4049/jimmunol.163.12.6876.
Pełny tekst źródłaLi, Bei, Yi-Li Zhang i Shou-Yi Yu. "Synovial Fluid Eotaxin-1 Levels May Reflect Disease Progression in Primary Knee Osteoarthritis Among Elderly Han Chinese: A Cross-Sectional Study". CARTILAGE 10, nr 4 (22.03.2018): 408–16. http://dx.doi.org/10.1177/1947603518764280.
Pełny tekst źródłaSanz, Maria-Jesus, Paul D. Ponath, Charles R. Mackay, Walter Newman, Masayuki Miyasaka, Tayuka Tamatani, Brian F. Flanagan i in. "Human Eotaxin Induces α4 and β2 Integrin-Dependent Eosinophil Accumulation in Rat Skin In Vivo: Delayed Generation of Eotaxin in Response to IL-4". Journal of Immunology 160, nr 7 (1.04.1998): 3569–76. http://dx.doi.org/10.4049/jimmunol.160.7.3569.
Pełny tekst źródłaMeng, Qiu, Andrew Menzies-Gow, Simon Phipps, richard Stillion, A. Barry Kay i Sun Ying. "Intracutaneous eotaxin and eotaxin-2 induces mRNA expression of IL-4, IL-5, eotaxin and eotaxin-2 in human atopic and non-atopic subjects". Journal of Allergy and Clinical Immunology 109, nr 1 (styczeń 2002): S61. http://dx.doi.org/10.1016/s0091-6749(02)81274-x.
Pełny tekst źródłaShinkai, Akeo, Hajime Yoshisue, Masamichi Koike, Emi Shoji, Satoshi Nakagawa, Akiko Saito, Tsuyoshi Takeda i in. "A Novel Human CC Chemokine, Eotaxin-3, Which Is Expressed in IL-4-Stimulated Vascular Endothelial Cells, Exhibits Potent Activity Toward Eosinophils". Journal of Immunology 163, nr 3 (1.08.1999): 1602–10. http://dx.doi.org/10.4049/jimmunol.163.3.1602.
Pełny tekst źródłaAgrawal, Devendra, Min-Jung Kim i Rohit Gaurav. "Differential effects of TGF-β1 on IL-5 and eotaxin-induced chloride currents in human blood eosinophils (P5130)". Journal of Immunology 190, nr 1_Supplement (1.05.2013): 58.19. http://dx.doi.org/10.4049/jimmunol.190.supp.58.19.
Pełny tekst źródłaYang, Yi, James Loy, Rolf-Peter Ryseck, Daniel Carrasco i Rodrigo Bravo. "Antigen-Induced Eosinophilic Lung Inflammation Develops in Mice Deficient in Chemokine Eotaxin". Blood 92, nr 10 (15.11.1998): 3912–23. http://dx.doi.org/10.1182/blood.v92.10.3912.
Pełny tekst źródłaHumbles, Alison A., Dolores M. Conroy, Sylvie Marleau, Sara M. Rankin, Roger T. Palframan, Amanda E. I. Proudfoot, Timothy N. C. Wells i in. "Kinetics of Eotaxin Generation and Its Relationship to Eosinophil Accumulation in Allergic Airways Disease: Analysis in a Guinea Pig Model In Vivo". Journal of Experimental Medicine 186, nr 4 (18.08.1997): 601–12. http://dx.doi.org/10.1084/jem.186.4.601.
Pełny tekst źródłaWang, Wen, Ci-You Huang, Zhuo-Ping Wang, Shan-Shan Xu, Tie-Yong Qian, Yi-Ding Chen i Wei-Guo Wu. "Serum C-C motif ligand 11/eotaxin-1 may serve as a candidate biomarker for postmenopausal osteoporosis". Journal of Medical Biochemistry 38, nr 3 (11.05.2019): 353–60. http://dx.doi.org/10.2478/jomb-2018-0042.
Pełny tekst źródłaMoore, Paul E., Trudi L. Church, David D. Chism, Reynold A. Panettieri i Stephanie A. Shore. "IL-13 and IL-4 cause eotaxin release in human airway smooth muscle cells: a role for ERK". American Journal of Physiology-Lung Cellular and Molecular Physiology 282, nr 4 (1.04.2002): L847—L853. http://dx.doi.org/10.1152/ajplung.00245.2001.
Pełny tekst źródłaFurer, Victoria, Eyal Hazan, Adi Mor, Michal Segal, Avi Katav, Valerie Aloush, Ori Elkayam, Jacob George i Jacob N. Ablin. "Elevated Levels of Eotaxin-2 in Serum of Fibromyalgia Patients". Pain Research and Management 2018 (2018): 1–4. http://dx.doi.org/10.1155/2018/7257681.
Pełny tekst źródłaNakamura, Hidetoshi, Kathleen J. Haley, Toshiko Nakamura, Andrew D. Luster i Craig M. Lilly. "Differential regulation of eotaxin expression by TNF-α and PMA in human monocytic U-937 cells". American Journal of Physiology-Lung Cellular and Molecular Physiology 275, nr 3 (1.09.1998): L601—L610. http://dx.doi.org/10.1152/ajplung.1998.275.3.l601.
Pełny tekst źródłaLamkhioued, B., P. M. Renzi, S. Abi-Younes, E. A. Garcia-Zepada, Z. Allakhverdi, O. Ghaffar, M. D. Rothenberg, A. D. Luster i Q. Hamid. "Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation." Journal of Immunology 159, nr 9 (1.11.1997): 4593–601. http://dx.doi.org/10.4049/jimmunol.159.9.4593.
Pełny tekst źródłaPeled, Amnon, Jose Angel Gonzalo, Clare Lloyd i Jose-Carlos Gutierrez-Ramos. "The Chemotactic Cytokine Eotaxin Acts as a Granulocyte-Macrophage Colony-Stimulating Factor During Lung Inflammation". Blood 91, nr 6 (15.03.1998): 1909–16. http://dx.doi.org/10.1182/blood.v91.6.1909.
Pełny tekst źródłaPeled, Amnon, Jose Angel Gonzalo, Clare Lloyd i Jose-Carlos Gutierrez-Ramos. "The Chemotactic Cytokine Eotaxin Acts as a Granulocyte-Macrophage Colony-Stimulating Factor During Lung Inflammation". Blood 91, nr 6 (15.03.1998): 1909–16. http://dx.doi.org/10.1182/blood.v91.6.1909.1909_1909_1916.
Pełny tekst źródłaNie, Mingrong, Qingxiang Zeng, Luo Xi, Yiquan Tang, Renzhong Luo i Wenlong Liu. "The Effect of IL-35 on the Expression of Nasal Epithelial-Derived Proinflammatory Cytokines". Mediators of Inflammation 2021 (3.12.2021): 1–7. http://dx.doi.org/10.1155/2021/1110671.
Pełny tekst źródłaTakamura, Kei, Yasuyuki Nasuhara, Motoko Kobayashi, Tomoko Betsuyaku, Yoko Tanino, Ichiro Kinoshita, Etsuro Yamaguchi, Satoshi Matsukura, Robert P. Schleimer i Masaharu Nishimura. "Retinoic acid inhibits interleukin-4-induced eotaxin production in a human bronchial epithelial cell line". American Journal of Physiology-Lung Cellular and Molecular Physiology 286, nr 4 (kwiecień 2004): L777—L785. http://dx.doi.org/10.1152/ajplung.00289.2003.
Pełny tekst źródłaPalframan, Roger T., Paul D. Collins, Timothy J. Williams i Sara M. Rankin. "Eotaxin Induces a Rapid Release of Eosinophils and Their Progenitors From the Bone Marrow". Blood 91, nr 7 (1.04.1998): 2240–48. http://dx.doi.org/10.1182/blood.v91.7.2240.
Pełny tekst źródłaPalframan, Roger T., Paul D. Collins, Timothy J. Williams i Sara M. Rankin. "Eotaxin Induces a Rapid Release of Eosinophils and Their Progenitors From the Bone Marrow". Blood 91, nr 7 (1.04.1998): 2240–48. http://dx.doi.org/10.1182/blood.v91.7.2240.2240_2240_2248.
Pełny tekst źródła